Our previous studies have demonstrated CDH17 as an oncofetal molecule with confirmed tumor-inducing potentials and tumorigenic properties in HCC that Wnt/β-catenin pathway is its downstream pathway leading to tumorigenesis [15], [34]. The gene discussed is CDH17; the disease is hepatocellular carcinoma.